Guangdong Taiantang Pharmaceutical Co.,Ltd. Posted 261.8 Million Yuan Net Loss in First Three Quarters of 2023

Guangdong Taiantang Pharmaceutical Co.,Ltd. (广东太安堂药业股份有限公司) (002433.SZ) reported a net loss of 261.8 million yuan in the first three quarters of 2023, widening 59.6% year-on-year.

Meanwhile, the company posted 378 million yuan in revenue, down 45.9% year-on-year.

At the end of the reporting period, it had 6 billion yuan in total assets and 2.6 billion yuan in total liabilities, with a liability-to-asset ratio of 42.7%.